RxDoctor Payments Data

Tamara Crowell, PA

Physician Assistant · Jacksonville, FLNPI 1497909451

Payments from drug & device makers

$13,352in general payments, 2019–2025

Across 643 payments — averaging $20.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$1K
  • AstraZeneca$1K
  • Otsuka America Pharmaceutical, Inc.$1K
  • AbbVie$1K
  • Abbott$896
  • Novo Nordisk$822
  • plus $7K from 52 others

What the payments were for

  • Food & beverage$13,25499%
  • Education$981%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK38$1,340
AstraZeneca62$1,263
Otsuka America Pharmaceutical, Inc.54$1,225
AbbVie49$1,013
Abbott54$896
Novo Nordisk49$822
Amgen(2 entities)35$821
Bayer39$691
Lilly USA, LLC35$589
Boehringer Ingelheim27$529
Corcept Therapeutics21$433
Takeda Pharmaceuticals U.S.A., Inc.17$423
Merck13$251
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC16$248
Sanofi-aventis U.S. LLC13$223
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)13$217
Recor Medical Inc1$166
Evoke Pharma, Inc.1$125
Xeris Pharmaceuticals, Inc.6$120
Abiomed1$120
Pfizer6$113
Sumitomo Pharma America, Inc.6$112
Johnson & Johnson(2 entities)5$102
Lundbeck LLC6$98
OPKO Pharmaceuticals, LLC5$98
Astellas Pharma US Inc5$86
Exact Sciences5$81
Grifols USA, LLC4$79
Novartis4$77
Scilex Pharmaceuticals Inc.4$73
Avanir Pharmaceuticals, Inc.4$62
Idorsia Pharmaceuticals US Inc4$61
Biohaven Pharmaceutical Holding Company Ltd.3$56
Sanofi Pasteur Inc.3$53
Boston Scientific1$52
Globus Medical2$51
Mylan Specialty L.p.2$48
Vanda Pharmaceuticals Inc.3$48
Axsome Therapeutics, Inc.2$43
Eisai Inc.2$36
Currax Pharmaceuticals LLC2$34
Daiichi Sankyo Inc.2$31
Inspire Medical Systems, Inc.1$31
Impulse Dynamics (USA) Inc.2$30
Medtronic2$29
GRT US Holding, Inc.1$28
Almatica Pharma LLC2$27
Scpharmaceuticals Inc.1$27
Philips North America LLC1$27
Phathom Pharmaceuticals, Inc.1$26
Teva Pharmaceuticals USA, Inc.1$18
VBI Vaccine (delaware) Inc.1$16
Dexcom, Inc.1$16
Insulet Corporation1$15
E.r. Squibb & Sons, L.L.C.1$15
Amarin Pharma, Inc.1$14
Nestle Healthcare Nutrition Inc.1$13
Lifescan, Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,352 in reported general payments places this provider in the 95th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$45,471
Medicare patients
140
Services billed
1,138

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide80$105,736
Trelegy ElliptaFluticasone/Umeclidin/Vilanter65$50,321
JardianceEmpagliflozin48$45,374
FarxigaDapagliflozin Propanediol31$33,541
MounjaroTirzepatide24$29,292
EliquisApixaban42$26,291
Janumet XrSitagliptin Phos/Metformin Hcl11$14,090
MyrbetriqMirabegron15$10,577
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr14$9,636
BelsomraSuvorexant18$7,547
LinzessLinaclotide13$7,123
Varenicline Tartrate20$6,550
Albuterol Sulfate HfaAlbuterol Sulfate156$4,725
SymbicortBudesonide/Formoterol Fumarate11$3,792
Tresiba Flextouch U-100Insulin Degludec11$3,690

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$822$105,73680 claims
GSKTrelegy Ellipta, Anoro Ellipta$1,340$59,95779 claims
Boehringer IngelheimJardiance$529$45,37448 claims
AstraZenecaFarxiga, Symbicort$1,263$37,33342 claims
Lilly USA, LLCMounjaro$589$29,29224 claims
PfizerEliquis$113$26,29142 claims
MerckJanumet Xr, Belsomra$251$21,63829 claims
Astellas Pharma US IncMyrbetriq$86$10,57715 claims
AbbVieLinzess, Synthroid$1,013$8,11131 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$223$3,47513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →